Sfoglia per Autore
RICTOR/mTORC2 downregulation in BRAFV600E melanoma cells promotes resistance to BRAF/MEK inhibition
2024-01-01 Ponzone, L.; Audrito, V.; Landi, C.; Moiso, E.; Levra Levron, C.; Ferrua, S.; Savino, A.; Vitale, N.; Gasparrini, M.; Avalle, L.; Vantaggiato, L.; Shaba, E.; Tassone, B.; Saoncella, S.; Orso, F.; Viavattene, D.; Marina, E.; Fiorilla, I.; Burrone, G.; Abili, Y.; Altruda, F.; Bini, L.; Deaglio, S.; Defilippi, P.; Menga, A.; Poli, V.; Porporato, P. E.; Provero, P.; Raffaelli, N.; Riganti, C.; Taverna, D.; Cavallo, F.; Calautti, E.
RICTOR/mTORC2 downregulation in BRAFV600E melanoma cells promotes resistance to BRAF/MEK inhibition
2024-01-01 Ponzone, Luca; Audrito, Valentina; Landi, Claudia; Moiso, Enrico; Levra Levron, Chiara; Ferrua, Sara; Savino, Aurora; Vitale, Nicoletta; Gasparrini, Massimiliano; Avalle, Lidia; Vantaggiato, Lorenza; Shaba, Enxhi; Tassone, Beatrice; Saoncella, Stefania; Orso, Francesca; Viavattene, Daniele; Marina, Eleonora; Fiorilla, Irene; Burrone, Giulia; Abili, Youssef; Altruda, Fiorella; Bini, Luca; Deaglio, Silvia; Defilippi, Paola; Menga, Alessio; Poli, Valeria; Porporato, Paolo Ettore; Provero, Paolo; Raffaelli, Nadia; Riganti, Chiara; Taverna, Daniela; Cavallo, Federica; Calautti, Enzo
Editorial: Understanding how myeloid cell development and function meet tissue distinct metabolic requirements
2024-01-01 Palmieri, E. M.; Salmond, R. J.; Menga, A.
FK506 bypasses the effect of erythroferrone in cancer cachexia skeletal muscle atrophy
2023-01-01 Mina, E.; Wyart, E.; Sartori, R.; Angelino, E.; Zaggia, I.; Rausch, V.; Maldotti, M.; Pagani, A.; Hsu, M. Y.; Friziero, A.; Sperti, C.; Menga, A.; Graziani, A.; Hirsch, E.; Oliviero, S.; Sandri, M.; Conti, L.; Kautz, L.; Silvestri, L.; Porporato, P. E.
Tumor growth of neurofibromin-deficient cells is driven by decreased respiration and hampered by NAD+ and SIRT3
2022-01-01 Masgras, I.; Cannino, G.; Ciscato, F.; Sanchez-Martin, C.; Darvishi, F. B.; Scantamburlo, F.; Pizzi, M.; Menga, A.; Fregona, D.; Castegna, A.; Rasola, A.
Iron supplementation is sufficient to rescue skeletal muscle mass and function in cancer cachexia
2022-01-01 Wyart, E.; Hsu, M. Y.; Sartori, R.; Mina, E.; Rausch, V.; Pierobon, E. S.; Mezzanotte, M.; Pezzini, C.; Bindels, L. B.; Lauria, A.; Penna, F.; Hirsch, E.; Martini, M.; Mazzone, M.; Roetto, A.; Geninatti Crich, S.; Prenen, H.; Sandri, M.; Menga, A.; Porporato, P. E.
The J2-immortalized murine macrophage cell line displays phenotypical and metabolic features of primary BMDMs in their M1 and M2 polarization state
2021-01-01 Spera, I.; Sanchez-Rodriguez, R.; Favia, M.; Menga, A.; Venegas, F. C.; Angioni, R.; Munari, F.; Lanza, M.; Campanella, A.; Pierri, C. L.; Canton, M.; Castegna, A.
IκBα targeting promotes oxidative stress-dependent cell death
2021-01-01 Carra, G.; Ermondi, G.; Riganti, C.; Righi, L.; Caron, G.; Menga, A.; Capelletto, E.; Maffeo, B.; Lingua, M. F.; Fusella, F.; Volante, M.; Taulli, R.; Guerrasio, A.; Novello, S.; Brancaccio, M.; Piazza, R.; Morotti, A.
N-acetylaspartate release by glutaminolytic ovarian cancer cells sustains protumoral macrophages
2021-01-01 Menga, A.; Favia, M.; Spera, I.; Vegliante, M. C.; Gissi, R.; De Grassi, A.; Laera, L.; Campanella, A.; Gerbino, A.; Carra, G.; Canton, M.; Loizzi, V.; Pierri, C. L.; Cormio, G.; Mazzone, M.; Castegna, A.
Pharmacological targets of metabolism in disease: Opportunities from macrophages
2020-01-01 Castegna, A.; Gissi, R.; Menga, A.; Montopoli, M.; Favia, M.; Viola, A.; Canton, M.
Editorial: Metabolism Meets Function: Untangling the Cross-Talk Between Signaling and Metabolism
2020-01-01 Castegna, A.; Mcvicar, D. W.; Campanella, A.; Palmieri, E. M.; Menga, A.; Porporato, P. E.
Cachexia, a systemic disease beyond muscle atrophy
2020-01-01 Wyart, E.; Bindels, L. B.; Mina, E.; Menga, A.; Stanga, S.; Porporato, P. E.
Understanding Metal Dynamics Between Cancer Cells and Macrophages: Competition or Synergism?
2020-01-01 Serra, M.; Columbano, A.; Ammarah, U.; Mazzone, M.; Menga, A.
Glufosinate constrains synchronous and metachronous metastasis by promoting anti-tumor macrophages
2020-01-01 Menga, Alessio.; Serra, Marina.; Todisco, S.; Riera-Domingo, C.; Ammarah, U.; Ehling, M.; Palmieri, E. M.; Di Noia, M. A.; Gissi, R.; Favia, M.; Pierri, C. L.; Porporato Paolo, Ettore; Castegna, A.; Mazzone, Massimiliano.
Impact of immunometabolism on cancer metastasis: A focus on T cells and macrophages
2020-01-01 Flerin, N. C.; Pinioti, S.; Menga, A.; Castegna, A.; Mazzone, M.
The crowded crosstalk between cancer cells and stromal microenvironment in gynecological malignancies: Biological pathways and therapeutic implication
2019-01-01 De Nola, R.; Menga, A.; Castegna, A.; Loizzi, V.; Ranieri, G.; Cicinelli, E.; Cormio, G.
SLC25A10 biallelic mutations in intractable epileptic encephalopathy with complex I deficiency
2018-01-01 Punzi, G.; Porcelli, V.; Ruggiu, M.; Hossain, M. F.; Menga, A.; Scarcia, P.; Castegna, A.; Gorgoglione, R.; Pierri, C. L.; Laera, L.; Lasorsa, F. M.; Paradies, E.; Pisano, I.; Marobbio, C. M. T.; Lamantea, E.; Ghezzi, D.; Tiranti, V.; Giannattasio, S.; Donati, M. A.; Guerrini, R.; Palmieri, L.; Palmieri, F.; De Grassi, A.
Monoamine oxidase-dependent histamine catabolism accounts for post-ischemic cardiac redox imbalance and injury
2018-01-01 Costiniti, V.; Spera, I.; Menabo, R.; Palmieri, E. M.; Menga, A.; Scarcia, P.; Porcelli, V.; Gissi, R.; Castegna, A.; Canton, M.
FOXD3 acts as a repressor of the mitochondrial S-adenosylmethionine carrier (SLC25A26) gene expression in cancer cells
2018-01-01 Cianciulli, Antonia; Menga, Alessio; Palmieri, Ferdinando; Iacobazzi., Vito
Metabolism and TAM functions—it takes two to tango
2018-01-01 Mazzone, Massimiliano; Menga, A.; Castegna, A.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| RICTOR/mTORC2 downregulation in BRAFV600E melanoma cells promotes resistance to BRAF/MEK inhibition | 1-gen-2024 | Ponzone, L.; Audrito, V.; Landi, C.; Moiso, E.; Levra Levron, C.; Ferrua, S.; Savino, A.; Vitale, N.; Gasparrini, M.; Avalle, L.; Vantaggiato, L.; Shaba, E.; Tassone, B.; Saoncella, S.; Orso, F.; Viavattene, D.; Marina, E.; Fiorilla, I.; Burrone, G.; Abili, Y.; Altruda, F.; Bini, L.; Deaglio, S.; Defilippi, P.; Menga, A.; Poli, V.; Porporato, P. E.; Provero, P.; Raffaelli, N.; Riganti, C.; Taverna, D.; Cavallo, F.; Calautti, E. | |
| RICTOR/mTORC2 downregulation in BRAFV600E melanoma cells promotes resistance to BRAF/MEK inhibition | 1-gen-2024 | Ponzone, Luca; Audrito, Valentina; Landi, Claudia; Moiso, Enrico; Levra Levron, Chiara; Ferrua, Sara; Savino, Aurora; Vitale, Nicoletta; Gasparrini, Massimiliano; Avalle, Lidia; Vantaggiato, Lorenza; Shaba, Enxhi; Tassone, Beatrice; Saoncella, Stefania; Orso, Francesca; Viavattene, Daniele; Marina, Eleonora; Fiorilla, Irene; Burrone, Giulia; Abili, Youssef; Altruda, Fiorella; Bini, Luca; Deaglio, Silvia; Defilippi, Paola; Menga, Alessio; Poli, Valeria; Porporato, Paolo Ettore; Provero, Paolo; Raffaelli, Nadia; Riganti, Chiara; Taverna, Daniela; Cavallo, Federica; Calautti, Enzo | |
| Editorial: Understanding how myeloid cell development and function meet tissue distinct metabolic requirements | 1-gen-2024 | Palmieri, E. M.; Salmond, R. J.; Menga, A. | |
| FK506 bypasses the effect of erythroferrone in cancer cachexia skeletal muscle atrophy | 1-gen-2023 | Mina, E.; Wyart, E.; Sartori, R.; Angelino, E.; Zaggia, I.; Rausch, V.; Maldotti, M.; Pagani, A.; Hsu, M. Y.; Friziero, A.; Sperti, C.; Menga, A.; Graziani, A.; Hirsch, E.; Oliviero, S.; Sandri, M.; Conti, L.; Kautz, L.; Silvestri, L.; Porporato, P. E. | |
| Tumor growth of neurofibromin-deficient cells is driven by decreased respiration and hampered by NAD+ and SIRT3 | 1-gen-2022 | Masgras, I.; Cannino, G.; Ciscato, F.; Sanchez-Martin, C.; Darvishi, F. B.; Scantamburlo, F.; Pizzi, M.; Menga, A.; Fregona, D.; Castegna, A.; Rasola, A. | |
| Iron supplementation is sufficient to rescue skeletal muscle mass and function in cancer cachexia | 1-gen-2022 | Wyart, E.; Hsu, M. Y.; Sartori, R.; Mina, E.; Rausch, V.; Pierobon, E. S.; Mezzanotte, M.; Pezzini, C.; Bindels, L. B.; Lauria, A.; Penna, F.; Hirsch, E.; Martini, M.; Mazzone, M.; Roetto, A.; Geninatti Crich, S.; Prenen, H.; Sandri, M.; Menga, A.; Porporato, P. E. | |
| The J2-immortalized murine macrophage cell line displays phenotypical and metabolic features of primary BMDMs in their M1 and M2 polarization state | 1-gen-2021 | Spera, I.; Sanchez-Rodriguez, R.; Favia, M.; Menga, A.; Venegas, F. C.; Angioni, R.; Munari, F.; Lanza, M.; Campanella, A.; Pierri, C. L.; Canton, M.; Castegna, A. | |
| IκBα targeting promotes oxidative stress-dependent cell death | 1-gen-2021 | Carra, G.; Ermondi, G.; Riganti, C.; Righi, L.; Caron, G.; Menga, A.; Capelletto, E.; Maffeo, B.; Lingua, M. F.; Fusella, F.; Volante, M.; Taulli, R.; Guerrasio, A.; Novello, S.; Brancaccio, M.; Piazza, R.; Morotti, A. | |
| N-acetylaspartate release by glutaminolytic ovarian cancer cells sustains protumoral macrophages | 1-gen-2021 | Menga, A.; Favia, M.; Spera, I.; Vegliante, M. C.; Gissi, R.; De Grassi, A.; Laera, L.; Campanella, A.; Gerbino, A.; Carra, G.; Canton, M.; Loizzi, V.; Pierri, C. L.; Cormio, G.; Mazzone, M.; Castegna, A. | |
| Pharmacological targets of metabolism in disease: Opportunities from macrophages | 1-gen-2020 | Castegna, A.; Gissi, R.; Menga, A.; Montopoli, M.; Favia, M.; Viola, A.; Canton, M. | |
| Editorial: Metabolism Meets Function: Untangling the Cross-Talk Between Signaling and Metabolism | 1-gen-2020 | Castegna, A.; Mcvicar, D. W.; Campanella, A.; Palmieri, E. M.; Menga, A.; Porporato, P. E. | |
| Cachexia, a systemic disease beyond muscle atrophy | 1-gen-2020 | Wyart, E.; Bindels, L. B.; Mina, E.; Menga, A.; Stanga, S.; Porporato, P. E. | |
| Understanding Metal Dynamics Between Cancer Cells and Macrophages: Competition or Synergism? | 1-gen-2020 | Serra, M.; Columbano, A.; Ammarah, U.; Mazzone, M.; Menga, A. | |
| Glufosinate constrains synchronous and metachronous metastasis by promoting anti-tumor macrophages | 1-gen-2020 | Menga, Alessio.; Serra, Marina.; Todisco, S.; Riera-Domingo, C.; Ammarah, U.; Ehling, M.; Palmieri, E. M.; Di Noia, M. A.; Gissi, R.; Favia, M.; Pierri, C. L.; Porporato Paolo, Ettore; Castegna, A.; Mazzone, Massimiliano. | |
| Impact of immunometabolism on cancer metastasis: A focus on T cells and macrophages | 1-gen-2020 | Flerin, N. C.; Pinioti, S.; Menga, A.; Castegna, A.; Mazzone, M. | |
| The crowded crosstalk between cancer cells and stromal microenvironment in gynecological malignancies: Biological pathways and therapeutic implication | 1-gen-2019 | De Nola, R.; Menga, A.; Castegna, A.; Loizzi, V.; Ranieri, G.; Cicinelli, E.; Cormio, G. | |
| SLC25A10 biallelic mutations in intractable epileptic encephalopathy with complex I deficiency | 1-gen-2018 | Punzi, G.; Porcelli, V.; Ruggiu, M.; Hossain, M. F.; Menga, A.; Scarcia, P.; Castegna, A.; Gorgoglione, R.; Pierri, C. L.; Laera, L.; Lasorsa, F. M.; Paradies, E.; Pisano, I.; Marobbio, C. M. T.; Lamantea, E.; Ghezzi, D.; Tiranti, V.; Giannattasio, S.; Donati, M. A.; Guerrini, R.; Palmieri, L.; Palmieri, F.; De Grassi, A. | |
| Monoamine oxidase-dependent histamine catabolism accounts for post-ischemic cardiac redox imbalance and injury | 1-gen-2018 | Costiniti, V.; Spera, I.; Menabo, R.; Palmieri, E. M.; Menga, A.; Scarcia, P.; Porcelli, V.; Gissi, R.; Castegna, A.; Canton, M. | |
| FOXD3 acts as a repressor of the mitochondrial S-adenosylmethionine carrier (SLC25A26) gene expression in cancer cells | 1-gen-2018 | Cianciulli, Antonia; Menga, Alessio; Palmieri, Ferdinando; Iacobazzi., Vito | |
| Metabolism and TAM functions—it takes two to tango | 1-gen-2018 | Mazzone, Massimiliano; Menga, A.; Castegna, A. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile